Viewing Study NCT02739633

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:47 AM
Ignite Modification Date: 2026-02-20 @ 6:05 PM
Study NCT ID: NCT02739633
Status: UNKNOWN
Last Update Posted: 2018-04-18
First Post: 2016-03-21
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Weekly Genexol®-PM Plus Gemcitabine in Subjects With Recurrent and Metastatic Adenocarcinoma of the Pancreas
Sponsor: Samyang Biopharmaceuticals Corporation
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Adenocarcinoma of the Pancreas View
None Metastatic Adenocarcinoma of the Pancreas View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chemotherapy View
None Gemcitabine View
None Recurrent and metastatic adenocarcinoma of the pancreas View
None Genexol-PM View
None Paclitaxel View